TUBERCULOSIS, MULTIDRUG-RESISTANT
Clinical trials for TUBERCULOSIS, MULTIDRUG-RESISTANT explained in plain language.
Never miss a new study
Get alerted when new TUBERCULOSIS, MULTIDRUG-RESISTANT trials appear
Sign up with your email to follow new studies for TUBERCULOSIS, MULTIDRUG-RESISTANT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Breakthrough trial aims to slash Drug-Resistant TB treatment time
Disease control Recruiting nowThis study tests whether a shorter, personalized treatment plan (called BPaLM) works as well as the standard longer treatment for people with a type of drug-resistant tuberculosis (TB). About 400 adults with fluoroquinolone-susceptible multidrug-resistant TB will be randomly assi…
Matched conditions: TUBERCULOSIS, MULTIDRUG-RESISTANT
Phase: PHASE2, PHASE3 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated May 17, 2026 14:28 UTC
-
Hope for kids with Hard-to-Treat TB: new drug combo under study
Disease control Recruiting nowThis study tests a drug called bedaquiline, given together with other TB medicines, in children and teens (birth to under 18 years) who have multidrug-resistant tuberculosis (MDR-TB) of the lungs. The goal is to see how safe the drug is, how the body processes it, and whether it …
Matched conditions: TUBERCULOSIS, MULTIDRUG-RESISTANT
Phase: PHASE2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
TB study seeks volunteers to unlock disease secrets
Knowledge-focused Recruiting nowThis study aims to learn more about tuberculosis (TB) by collecting blood and other samples from people who have active or latent TB. Researchers want to better understand how the disease works and how it affects the body. Participants will provide samples and may receive treatme…
Matched conditions: TUBERCULOSIS, MULTIDRUG-RESISTANT
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated May 17, 2026 14:26 UTC